BCM
Bayesian Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,000
| Closed | -$686K | – | 845 |
|
|
2024
Q2 | $686K | Buy |
+5,000
| New | +$686K | 0.08% | 299 |
|
|
2024
Q1 | – | Sell |
-2,122
| Closed | -$288K | – | 929 |
|
|
2023
Q4 | $288K | Buy |
+2,122
| New | +$288K | 0.03% | 526 |
|
|
2022
Q4 | – | Sell |
-3,510
| Closed | -$411K | – | 884 |
|
|
2022
Q3 | $411K | Sell |
3,510
-2,779
| -44% | -$325K | 0.08% | 333 |
|
|
2022
Q2 | $740K | Buy |
+6,289
| New | +$740K | 0.14% | 229 |
|
|
2021
Q3 | – | Sell |
-3,400
| Closed | -$556K | – | 455 |
|
|
2021
Q2 | $556K | Buy |
+3,400
| New | +$556K | 0.15% | 176 |
|
|
2020
Q4 | – | Sell |
-5,894
| Closed | -$798K | – | 555 |
|
|
2020
Q3 | $798K | Buy |
+5,894
| New | +$798K | 0.2% | 141 |
|
|
2020
Q1 | – | Sell |
-3,572
| Closed | -$430K | – | 859 |
|
|
2019
Q4 | $430K | Buy |
+3,572
| New | +$430K | 0.07% | 338 |
|